EvaluatePharma forecasts that NVS will be #1 in the world in prescription-drug sales starting in 2014 and will hold the top rank through 2018; PFE and SNY will hold the #2 and #3 slots (or vice-versa) during this period: http://finance.yahoo.com/news/evaluatepharma-2018-outlook-novartis-1-110000993.html